🏥 Cabinet Approves $ 908,250 Emergency Antibiotic Procurement

The Cabinet of Ministers has cleared an urgent order for 865,000 vials of Meropenem to address rising clinical demand within the public health system. • Procurement Details: The supplementary order is valued at US$ 908,250 (including freight) and will be supplied by United Biotech Ltd., India. • Volume Increase: This represents a 45.53% increase over the original procurement of 1.9 million vials approved in October 2025. • Cost Efficiency: The order was secured at the original unit price of $ 1.05 per vial, avoiding additional costs despite the sharp rise in demand. • Healthcare Impact: Meropenem is a critical antibiotic used for severe and drug-resistant bacterial infections, primarily in ICUs and emergency units. • Strategic Context: The decision ensures continuity in the pharmaceutical supply chain, vital for national health security and maintaining the operational capacity of state hospitals. _Source: Cabinet Decisions, May 2026_ 📈